Evaluation of EGFR degradation as a mechanism of tumor evasion in EGFR-TKI resistant non-small cell lung cancer (NSCLC) cells compared to EGFR-TKI sensitive cells

被引：0
|
作者：
Norma, Hernandez-Pedro Y. [1 ]
Giovanny, Soca-Chafre [1 ]
Mario, Orozco-Morales [1 ]
Pedro, Barrios-Bernal [1 ]
Oscar, Arrieta [1 ]
机构：
[1] Inst Nacl Cancerol, Mexico City, DF, Mexico
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-LB-186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-186
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
    Cao, Peijun
    Li, Yongwen
    Shi, Ruifeng
    Yuan, Yin
    Gong, Hao
    Zhu, Guangsheng
    Zhang, Zihe
    Chen, Chen
    Zhang, Hongbing
    Liu, Minghui
    Pan, Zhenhua
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [32] Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI
    Ding, Jianghua
    Ding, Xingjing
    Zeng, Jiao
    Liu, Xiaoqun
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [33] Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
    Li, Fang
    Zhu, Tengjiao
    Cao, Baoshan
    Wang, Jiadong
    Liang, Li
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 184 - 192
  • [34] VEGFA mediates traditional EGFR-TKI resistance in non-small cell lung cancer with EGFR exon 20 insertions
    Yang, Yaning
    Liu, Chengming
    Yang, Guangjian
    Xu, Haiyan
    Lei, Siyu
    Wang, Yan
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Autophagy facilitates the EGFR-TKI acquired resistance of non-small-cell lung cancer cells
    Liu, Donglei
    Yang, Yang
    Zhao, Song
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (03) : 141 - 142
  • [36] Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer
    Takeda, Masayuki
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    LUNG CANCER, 2015, 88 (01) : 74 - 79
  • [37] Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer
    Takeda, Masayuki
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2015, 26 : 83 - 84
  • [38] The advance of the third-generation EGFR-TKI in the treatment of non-small cell lung cancer
    Cheng, Zhinan
    Cui, Hongwei
    Wang, Yaqi
    Yang, Jin
    Lin, Chunyang
    Shi, Xiaoyu
    Zou, Yuxiu
    Chen, Jing
    Jia, Xiaoqiong
    Su, Liqing
    ONCOLOGY REPORTS, 2024, 51 (01)
  • [39] Effect of EGFR-TKI targeted therapy in patients with advanced non-small cell lung cancer
    Yan, Meihao
    Chen, Shanshan
    Fan, Hongtao
    Hong, Yuancheng
    Huang, Wencheng
    Lin, Zhimin
    Lai, Zhangchao
    Hong, Liyue
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (11): : 7916 - 7923
  • [40] Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation
    Anai, Moriyasu
    Saruwatari, Koichi
    Imamura, Kosuke
    Fujino, Kosuke
    Jodai, Takayuki
    Sakata, Shinya
    Iyama, Shinji
    Tomita, Yusuke
    Saeki, Sho
    Ichiyasu, Hidenori
    Ikeda, Koei
    Suzuki, Makoto
    Sakagami, Takuro
    JOURNAL OF THORACIC DISEASE, 2024, 16 (02) : 1151 - 1160
12345